The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were previously out of reach for seniors.
Recent Posts
- U.S. won’t renew USMCA, opening door for negotiations with Canada and Mexico
- Prolific tech analyst Dan Ives is exiting Wedbush for a new venture
- Warsh faces multiple alternative inflation signs as Fed charts new course
- Inflation peaked in May as energy prices fell in June, Kalshi traders think
- Trump administration’s limits on student loan forgiveness program are blocked. What to know